Sun Pharmaceutical Industries Inc. (Sun Pharma), the fourth largest specialty generic pharmaceutical company globally, is offering a summer internship program in 2025 for students to gain ...

New Delhi: Sun Pharmaceutical Industries (Sun Pharma) has launched its corporate brand campaign, aiming to highlight its impact on the lives of people. Created by Ogilvy Mumbai, the campaign is ...

President Bola Ahmed Tinubu has extended warm congratulations to veteran journalist and publisher, Chief Monsor Olowosago, as the Oriwu Sun community newspaper marks its 40th anniversary in the ...

President Bola Ahmed Tinubu has extended warm congratulations to veteran journalist and publisher, Chief Monsor Olowosago, as the Oriwu Sun community newspaper marks its 40th anniversary on the ...

The New Jersey Economic Development Authority board March 12 approved $5.24 million in tax credits under the Emerge Program to support Sun Pharmaceutical Inds. Inc.’s new U.S. headquarters in ...

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio ...

Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal.

I write about Asia's richest, fast-growing businesses, and startups. Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy ...

MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Sun Pharma’s acquisition of Checkpoint Therapeutics includes Unloxcyt, an FDA-approved anti-PD-L1 therapy for metastatic and locally advanced cutaneous squamous cell carcinoma. Sun Pharma announced ...

Sun Pharma Q3 Results: Sun Pharmaceutical Industries on Friday said its consolidated net profit increased 15 per cent on-year to Rs 2,903 crore in the December quarter, riding on robust sales across ...